AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RHYTHM BIOSCIENCES LTD

0.225

+0.0104.65%

Volume:157.51K

Turnover:34.84K

Market Cap:73.37M

PE:-16.07

High:0.225

Open:0.220

Low:0.210

Close:0.215

52wk High:0.280

52wk Low:0.047

Shares:326.07M

Float Shares:188.31M

Volume Ratio:0.42

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.014

EPS(LYR):-0.014

ROE:-501.54%

ROA:-107.16%

PB:111.18

PE(LYR):-15.82

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Rhythm Biosciences Signs Distribution Deal With Pathology Company; Shares Up 10%

MT Newswires Live

BRIEF-Rhythm Biosciences Enters ColoSTAT Services Agreement With 4Cyte Pathology

Rhythm Biosciences Ltd - Enters Colostat Services Agreement With 4Cyte Pathology

THOMSON REUTERS

Rhythm Biosciences Enrolls First Physician Participant in Colorectal Cancer Detection Test Program; Shares Jump 9%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RHY.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RHY.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","market":"AU","secType":"STK","nameCN":"RHYTHM BIOSCIENCES LTD","latestPrice":0.225,"timestamp":1771463210596,"preClose":0.215,"halted":0,"volume":157505,"delay":0,"changeRate":0.046511627906976785,"nameEN":"RHYTHM BIOSCIENCES LTD","floatShares":188306561,"shares":326068419,"eps":-0.014,"marketStatus":"Trading","change":0.01,"latestTime":"02-19 12:13:39 AEDT","open":0.22,"high":0.225,"low":0.21,"amount":34839,"amplitude":0.069767,"askPrice":0.225,"askSize":332783,"bidPrice":0.215,"bidSize":29106,"shortable":3,"etf":0,"ttmEps":-0.014,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771477200000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.215,"openAndCloseTimeList":[[1771455600000,1771477200000]],"volumeRatio":0.422653,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","floatShares":188306561,"roa":"-107.16%","roe":"-501.54%","lyrEps":-0.014222,"volumeRatio":0.422653,"shares":326068419,"dividePrice":0,"high":0.225,"amplitude":0.069767,"preClose":0.215,"low":0.21,"week52Low":0.047,"pbRate":"111.18","psRate":"22.98","week52High":0.28,"institutionHeld":0,"latestPrice":0.225,"committee":-0.839144,"eps":-0.014,"divideRate":0,"volume":157505,"delay":0,"ttmEps":-0.014,"open":0.22,"prevYearClose":0.135,"prevWeekClose":0.21,"prevMonthClose":0.145,"prevQuarterClose":0.135,"fiveDayClose":0.24,"twentyDayClose":0.16,"sixtyDayClose":0.086,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RHY.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-07-27","symbol":"RHY.AU","type":"split","dateTimestamp":1595772000000,"forFactor":875,"toFactor":1000,"ratio":0.875}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RHY.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RHY.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612943981","title":"Rhythm Biosciences Signs Distribution Deal With Pathology Company; Shares Up 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612943981","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612943981?lang=en_us&edition=fundamental","pubTime":"2026-02-17 10:50","pubTimestamp":1771296649,"startTime":"0","endTime":"0","summary":"Rhythm Biosciences  entered into a distribution service agreement with 4Cyte Pathology for its ColoSTAT diagnostic test for the detection of colorectal cancer, according to a Tuesday filing with the Australian bourse.4Cyte will integrate ColoSTAT into its clinical ordering system across its network of patient collection centers in New South Wales, Victoria, and Queensland, with no minimum volume commitments or upfront payments under the deal, the filing said.The deal has an initial three-year term and an option for a two-year extension by mutual agreement, per the filing.Rhythm Biosciences shares rose nearly 10% in afternoon trade on Tuesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2612884438","title":"BRIEF-Rhythm Biosciences Enters ColoSTAT Services Agreement With 4Cyte Pathology","url":"https://stock-news.laohu8.com/highlight/detail?id=2612884438","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612884438?lang=en_us&edition=fundamental","pubTime":"2026-02-17 06:21","pubTimestamp":1771280464,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Enters ColoSTAT Services Agreement With 4Cyte PathologyFeb 17 (Reuters) - Rhythm Biosciences Ltd RHY.AX:ENTERS COLOSTAT SERVICES AGREEMENT WITH 4CYTE PATHOLOGYFurther company coverage: RHY.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260216:nFWN3ZC0GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"gpt_icon":0},{"id":"2612696480","title":"Rhythm Biosciences Ltd -  Enters Colostat Services Agreement With 4Cyte Pathology","url":"https://stock-news.laohu8.com/highlight/detail?id=2612696480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612696480?lang=en_us&edition=fundamental","pubTime":"2026-02-17 05:39","pubTimestamp":1771277998,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260216:nFWN3ZC0GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"gpt_icon":0},{"id":"2610606565","title":"Rhythm Biosciences Enrolls First Physician Participant in Colorectal Cancer Detection Test Program; Shares Jump 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610606565","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610606565?lang=en_us&edition=fundamental","pubTime":"2026-02-11 10:03","pubTimestamp":1770775389,"startTime":"0","endTime":"0","summary":"Rhythm Biosciences  enrolled the first physician participant in its ColoSTAT Access Program, a commercial deployment framework for its blood-based test for the detection of colorectal cancer, according to a Wednesday Australian bourse filing.Under the program, participating clinicians receive an initial allocation of ColoSTAT tests at no cost and continued use of the test after the initial allocation is expected to be on a paid basis, the filing said. The program will be capped at 20 participants in Australia.Rhythm Biosciences' shares jumped nearly 9% in recent trading on Wednesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7124","RHY.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RHY.AU\",params:#limit:6,delay:true,,,undefined,":[]}}